Concepedia

Geoffrey Fell

GF

Statistics

Publications

11

Citations

677

H-Index

11

Active since

2021

Affiliations

Dana-Farber Cancer Institute(Current)

Harvard University

Brigham and Women's Hospital

Massachusetts General Hospital

Broad Institute

Geoffrey Fell is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

2021–2025

11

Publications

11

Clinical trial links oncolytic immunoactivation to survival in glioblastoma

Alexander Ling, Isaac H. Solomon, Ana Montalvo Landivar et al. · Nature · 2023 · 256 citations · Full text

, , +17

Fine tuning of CpG spatial distribution with DNA origami for improved cancer vaccination

Yang C. Zeng, Olivia J. Young, Christopher M. Wintersinger et al. · Nature Nanotechnology · 2024 · 156 citations

, , +17

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

Jacqueline S. Garcia, Haesook T. Kim, H. Moses Murdock et al. · Blood Advances · 2024 · 43 citations · Full text

, , +17

TOP1 Mutations and Cross-Resistance to Antibody–Drug Conjugates in Patients with Metastatic Breast Cancer

Rachel O. Abelman, Bogang Wu, Haley Barnes et al. · Clinical Cancer Research · 2025 · 40 citations · Full text

, , +17

Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects

Deborah Plana, Geoffrey Fell, Brian M. Alexander et al. · Nature Communications · 2022 · 39 citations · Full text

, , +14

1–5 of 11